EBS
Emergent Biosolutions Inc
6.80$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.22 | 5.33 | 5.75 | 4.84 | 5.28 | 3.59 | 3.88 | 2.60 | 4.09 | 2.84 | 2.76 | 4.54 | 14.93 | |
| 3.44 | 2.07 | 3.06 | 6.09 | 2.33 | 1.07 | 1.84 | 1.54 | 1.81 | 1.95 | 1.57 | 1.88 | 7.55 | |
| 1.78 | 3.26 | 2.70 | -1.25 | 2.95 | 2.52 | 2.03 | 1.06 | 2.28 | 0.89 | 1.20 | 2.66 | 7.37 | |
| 0.30 | 0.57 | 0.29 | 0.62 | 0.25 | 0.17 | 0.27 | 0.24 | 0.24 | 0.23 | 0.19 | 0.18 | 0.88 | |
| 1.66 | 1.73 | 1.62 | 1.63 | 1.38 | 1.12 | 0.91 | 0.81 | 0.69 | 0.98 | 0.82 | 0.86 | 3.51 | |
| 6.46 | 4.10 | 1.93 | 2.62 | 1.79 | 2.69 | 1.18 | 1.05 | 0.93 | 1.21 | 1.01 | 5.08 | 8.43 | |
| -4.67 | -0.84 | 0.76 | -3.87 | 1.16 | -0.18 | 0.85 | 0.01 | 1.36 | -0.32 | 0.19 | -2.42 | -1.05 | |
| 0.38 | 0.43 | 0.47 | 0.45 | 0.15 | 0.27 | 0.26 | 0.27 | 0.27 | 0.28 | 0.19 | 0.19 | 0.99 | |
| -5.13 | -1.05 | 0.23 | -5.13 | 2.56 | -0.51 | 1.62 | -0.31 | 1.02 | -0.97 | 0.24 | -3.22 | -2.83 | |
| -0.05 | -0.10 | 0.06 | 0.25 | 0.50 | 0.07 | 0.43 | -0.09 | 0.11 | 0.07 | 0.12 | 0.27 | 0.60 | |
| -5.08 | -0.95 | 0.17 | -5.38 | 2.06 | -0.58 | 1.19 | -0.22 | 0.91 | -1.04 | 0.12 | -3.49 | -3.43 | |
| 0.45 | -0.26 | 1.21 | -2.50 | 1.76 | 0.39 | 2.33 | 0.40 | 1.71 | -0.24 | 0.86 | -3.03 | -0.46 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.